BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17637556)

  • 21. [Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
    Tokairin Y; Iida M; Yamazaki S
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2123-5. PubMed ID: 19106544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1].
    Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of locally advanced pancreas cancer effectively treated by multidisciplinary strategy].
    Hasegawa K; Katsuta E; Iwata N; Aoyagi H; Yoshida T; Takahata T; Kaneko J; Maejima S
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2152-4. PubMed ID: 22202313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine].
    Akiyama N; Ayata S; Maruyama Y; Tsukada Y
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1591-3. PubMed ID: 20716894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study.
    Zhou J; Zhao R; Wen F; Zhang P; Tang R; Du Z; He X; Zhang J; Li Q
    Med Oncol; 2015 Apr; 32(4):121. PubMed ID: 25788034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.
    Yamauchi J; Kanai M; Matsumoto S; Nishimura T; Yazumi S; Kami K; Kawaguchi Y; Yasuda H; Kitano T; Misawa A; Ishiguro H; Yoshikawa K; Yanagihara K; Fukushima M; Doi R; Chiba T
    Pancreas; 2008 Apr; 36(3):327-8. PubMed ID: 18362852
    [No Abstract]   [Full Text] [Related]  

  • 27. [S-1+gemcitabine (GEM) therapy was effective in a case of unresectable pancreatic head carcinoma].
    Takada J; Okuda K; Kenno S; Shimada S; Oba G; Shimokuni T; Aoki T; Hamada H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2120-2. PubMed ID: 19106543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
    Ishikawa T; Mizuno K; Watanabe K; Baba Y; Oota H; Yoshida T; Kamimura T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1555-8. PubMed ID: 15508450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
    Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
    Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].
    Yoshida Y; Sugawara N; Minami T; Iwata N; Ikeda K; Endoh T; Sasano H
    Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):660-8. PubMed ID: 23558130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective study of gemcitabine plus S-1 versus gemcitabine alone in cases with unresectable advanced pancreatic cancer.
    Suzuki S; Ozaki Y; Saida S; Kaji S; Koike N; Harada N; Hayashi T; Suzuki M
    Hepatogastroenterology; 2013 Jun; 60(124):916-20. PubMed ID: 23478143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adjuvant Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer following Gemcitabine and S-1 Chemotherapy--A Case Report].
    Tono T; Kawasaki Y; Hashimoto M; Ikeda Y; Senba H; Okubo Y; Katayama T; Ishii T; Shinozaki K; Hayashi H; Yasuda S; Ohtsuru M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2373-5. PubMed ID: 26805368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-1 and gemcitabine as an outpatient-based regimen in patients with advanced or metastatic pancreatic cancer.
    Kim MK; Lee KH; Jang BI; Kim TN; Eun JR; Bae SH; Ryoo HM; Lee SA; Hyun MS
    Jpn J Clin Oncol; 2009 Jan; 39(1):49-53. PubMed ID: 19060295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
    Maeda T; Tsuchiya M; Ishii J; Koda T; Kubota Y; Katagiri T; Tamura A; Otsuka Y; Shibuya K; Kaneko H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2184-6. PubMed ID: 25731464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-Term Survival Due to Combination Therapy in a Patient with Locally Advanced Body-Tail Pancreatic Cancer].
    Ueda N; Fujii Y; Miura S; Fujita J; Tomita Y; Ohnishi T; Fujita H; Kinami S; Omote K; Nakano Y; Kosaka T; Motoo Y
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1373-1375. PubMed ID: 29394638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The addition of S-1 to gemcitabine-based chemotherapy improves survival with increased toxicity for patients with advanced pancreatic cancer: combined meta-analysis of efficacy and safety profile.
    Liu Y; Huang QK; Hong WD; Wu JM; Sun XC
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):254-60. PubMed ID: 25304193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts.
    Nakahira S; Nakamori S; Tsujie M; Takeda S; Sugimoto K; Takahashi Y; Okami J; Marubashi S; Miyamoto A; Takeda Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Anticancer Res; 2008; 28(1A):179-86. PubMed ID: 18383843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adjuvant gemcitabine plus S-1 chemotherapy for pancreatic cancer after surgical resection - outcomes and future perspectives].
    Murakami Y; Uemura K; Sudo T
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1661-9. PubMed ID: 21971141
    [No Abstract]   [Full Text] [Related]  

  • 39. Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case.
    Okada K; Imaizumi T; Yazawa N; Matsuyama M; Dowaki S; Tobita K; Hirabayashi K; Makuuchi H
    Tokai J Exp Clin Med; 2009 Jul; 34(2):53-7. PubMed ID: 21318999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].
    Okada T; Sakurai N; Yamamoto K; Motoi F; Kakizaki Y; Tamura G; Unno M; Iizawa H
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):135-7. PubMed ID: 22241369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.